Sign in

ALDV

EURONEXT:ALDVI

Advicenne S.A.

  • Stock

EUR

Last Close

1.02

26/07 15:39

Market Cap

25.18M

Beta: 1.18

Volume Today

63.70K

Avg: 20.03K

PE Ratio

−1.48

PFCF: −2.27

OverviewFinancialsFilingspeopleAPIChartData

  • locale

    frFrance

  • market

    STOCKS

  • industry

    Biotechnology

  • website

    www.advicenne.com

  • ipo date

    Dec 06, 2017

Advicenne S.A., a specialty pharmaceutical company, develops and commercializes treatments for nephrology. Its lead product candidate is Sibnayal for the treatment of distal renal tubular acidosis, as well as for the treatment of cystinuria. Advicenne S.A. was founded in 2007 and is headquartered in Paris, France.

peer of

Earnings

Earnings per Share (Estimate*)

0.0020.0040.0060.0080.012017-11-222019-09-232021-04-282023-01-242024-03-27

Revenue (Estimate*)

0.000.000.010.010.012017-11-222019-09-232021-04-282023-01-242024-03-27

*Estimate based on analyst consensus